The Effect of Chronobiologic Feeding Model on Circadian Rhythm in Newborns

Status Recruiting

Clinical Trial Summary

This study was planned to evaluate the effect of "feeding model with chronobiologic approach" on circadian rhythm, growth and physiologic parameters of newborns.

Clinical Trial Description

The newborn period is a period when all babies need their basic needs to be met and all babies are very sensitive physiologically, neuro-biologically and psycho-emotionally, but the newborn period is also a very important period in the development of circadian rhythm. It is important to establish a healthy sleep pattern for the formation of the circadian rhythm and the continuation of the functions of all other systems, especially the central nervous system. Formation of circadian rhythm in newborns; It shows a better development in the first 3 months with the effect of environmental factors such as nutrition, light, mother-baby interaction. Breast milk is a nutrient for the growth and development of babies, in addition, breast milk plays an active role in the formation of the baby's circadian rhythm by transmitting information about the time of day to the babies through components such as hormones and immune elements. In cases where breastfeeding is not possible, it is thought that the delivery of expressed breast milk to the babies simultaneously with the "feeding model with a chronobiological approach" has important effects on the sleep-wake cycle and growth and development. In studies examining circadian rhythm in newborns in the world and in our country, the limited number of studies evaluating the relationship between circadian rhythm and breast milk draws attention and further studies are recommended. However, there is no published study evaluating the effect of simultaneous administration of breast milk to the infant in line with the "feeding model with chronobiologic approach" on circadian rhythm, growth and physiologic parameters of newborns. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05923437
Study type	Interventional
Source	Selcuk University
Contact	Sibel Kucukoglu
Phone	+903322231623
Email	s_nadaroglu@hotmail.com
Status	Recruiting
Phase	N/A
Start date	August 1, 2023
Completion date	February 28, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03297567` - Physical Therapy Guidelines For Hospitalized Elderly	N/A
Terminated	`NCT03825497` - The WALK-Copenhagen Trial (WALK-Cph): a Mixed Methods Study	N/A
Completed	`NCT06293768` - Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T)	N/A
Completed	`NCT03296423` - Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly	Phase 4
Not yet recruiting	`NCT05550272` - Hospitalizations in Neonatal Period and Early Discharge of Maternity
Completed	`NCT02614638` - Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy	N/A
Completed	`NCT01931553` - A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine	N/A
Completed	`NCT00527774` - Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients	N/A
Completed	`NCT02598115` - Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older	N/A
Recruiting	`NCT05366075` - The Preventing Functional Decline in Acutely Hospitalized Older Patients (PREV_FUNC) Study	Phase 3
Not yet recruiting	`NCT05522647` - Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
Terminated	`NCT04257422` - Intentional Rounding in Internal Medicine	N/A
Completed	`NCT00370916` - Reducing Transition Drug Risk	N/A
Completed	`NCT00244673` - Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination	Phase 4
Recruiting	`NCT04078334` - Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization	N/A
Active, not recruiting	`NCT04235374` - Implementation of Function Focused Care in Acute Care	N/A
Recruiting	`NCT03651414` - Safety Issues and SurvIval For Medical Outliers
Completed	`NCT05247060` - Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine
Terminated	`NCT05518474` - Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness	N/A
Recruiting	`NCT05036824` - Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.